allay Hydrogel Cap
Reduction of risk of symptomatic neuroma formation after peripheral nerve transection
CommercialActive
Key Facts
Indication
Reduction of risk of symptomatic neuroma formation after peripheral nerve transection
Phase
Commercial
Status
Active
Company
About Tulavi Therapeutics
Tulavi Therapeutics is a private, commercial-stage medical device company based in San Diego, leveraging its proprietary Adaptive Hydrogel Technology to improve outcomes in peripheral nerve surgery. Its lead product, the allay Hydrogel Cap, is the first and only fully absorbable device specifically indicated to reduce the risk of symptomatic neuroma formation, targeting a large market of over 1.8 million annual peripheral nerve procedures. Backed by the Incept accelerator and with initial peer-reviewed clinical data published, Tulavi is positioned to capture share in a space historically reliant on inconsistent surgical techniques.
View full company profile